Autotransfusion Devices Market Regional Analysis:
APAC Market Insights
Asia Pacific market is projected to dominate majority share by 2035 owing to the entry of new industry players, and the increasing acceptance of cell salvage technologies. Furthermore, the steadily expanding number of surgeries performed in China and India, along with the emerging health services, are expected to create significant growth possibilities for the region. According to the most recent statistical report, Chinese hospitals operated more than 81 million inpatient surgeries in 2021.
North American Market Insights
The North America autotransfusion devices market is projected to hold significant share by the end of 2035. The growth of the market can be ascribed to the account of higher cases of chronic disease among the population propelling the market growth in the United States. According to the Centers for Disease Control and Prevention, every 6 in 10 adults are living with a chronic disease, and every 4 in 10 have more than 1 chronic problem. Furthermore, there has been a rise in organ transplantation and other surgeries in the region, that is further predicted to surge the market’s growth in the region. In the United States, at the current time, nearly 121,000 people are waiting for kidney transplantation. Also, the region's sales growth is expected to be driven by the rising usage of autologous blood transfusion in significant cardiovascular and orthopedic surgeries, in addition to the existence of established healthcare facilities. For instance, as per the American Association of Blood Banks guidelines, postoperative and intraoperative autotransfusion are conducted in surgeries in which 20% of overall surgical bleeding is anticipated.
